ARS PHARMACEUTICALS INC (SPRY) Institutional Ownership Changes & 13F Activity
ARS PHARMACEUTICALS INC (SPRY). Institutional ownership data tracks hedge funds, asset managers, and other institutional investors based on recent SEC Form 13F filings (Q2 2026). This page analyzes institutional buying and selling activity, new holdings, and sold-out positions in the latest reporting period. Notable filers include Millennium Management Llc, Boothbay Fund Management, Llc, Citadel Advisors Llc, Adar1 Capital Management, Llc, and Rubric Capital Management Lp.
| Institution | Type | Change in shares | Change Position % | Shares | Reported stock balance | Portfolio quarter | Filing date |
|---|---|---|---|---|---|---|---|
| Manufacturers Life Insurance Company, The | Buy | +681 | +4.1% | 17,318 | $138.72K | Q2 2026 | Sep 09, 2026 |
| Citadel Advisors Llc | Sell | -1,242,125 | -70.1% | 531,063 | $4.25M | Q2 2026 | Sep 02, 2026 |
| Allianz Asset Management Gmbh | Buy | +10,200 | — | 10,200 | $81.70K | Q2 2026 | Sep 02, 2026 |
| Corient Private Wealth Llc | Buy | +10,099 | +12.5% | 91,042 | $729.25K | Q2 2026 | Aug 27, 2026 |
| California State Teachers Retirement System | Sell | -7,535 | -14.0% | 46,123 | $369.44K | Q2 2026 | Aug 24, 2026 |
| Bernard Wealth Management Corp. | Sell | -100 | -4.0% | 2,420 | $19.39K | Q2 2026 | Aug 21, 2026 |
| Coastal Bridge Advisors, Llc | Buy | +108 | +0.2% | 55,838 | $447.26K | Q2 2026 | Aug 17, 2026 |
| Millennium Management Llc | Sell | -3,581,982 | -59.9% | 2,400,937 | $19.23M | Q2 2026 | Aug 14, 2026 |
| Boothbay Fund Management, Llc | Buy | +1,350,907 | +539.1% | 1,601,504 | $12.83M | Q2 2026 | Aug 14, 2026 |
| Adar1 Capital Management, Llc | Sell | -760,537 | -55.9% | 600,999 | $4.81M | Q2 2026 | Aug 14, 2026 |
| Rubric Capital Management Lp | Buy | +540,861 | +6.8% | 8,540,861 | $68.41M | Q2 2026 | Aug 14, 2026 |
| Goldman Sachs Group Inc | Sell | -343,449 | -47.4% | 380,770 | $3.05M | Q2 2026 | Aug 14, 2026 |
| Trexquant Investment Lp | Buy | +286,733 | — | 286,733 | $2.30M | Q2 2026 | Aug 14, 2026 |
| Eversept Partners, Lp | Buy | +240,772 | +176.7% | 377,007 | $3.02M | Q2 2026 | Aug 14, 2026 |
| Raymond James Financial Inc | Sell | -206,641 | -39.3% | 318,583 | $2.55M | Q2 2026 | Aug 14, 2026 |
| Xtx Topco Ltd | Sell | -202,921 | -73.5% | 73,187 | $586.23K | Q2 2026 | Aug 14, 2026 |
| Bank Of America Corp | Buy | +177,528 | +62.1% | 463,256 | $3.71M | Q2 2026 | Aug 14, 2026 |
| Ishara Investments Lp | Buy | +143,490 | — | 143,490 | $1.15M | Q2 2026 | Aug 14, 2026 |
| Parkman Healthcare Partners Llc | Buy | +102,700 | — | 102,700 | $822.63K | Q2 2026 | Aug 14, 2026 |
| Engineers Gate Manager Lp | Buy | +92,163 | +195.0% | 139,419 | $1.12M | Q2 2026 | Aug 14, 2026 |
| Sei Investments Co | Buy | +91,660 | +706.0% | 104,643 | $838.19K | Q2 2026 | Aug 14, 2026 |
| Squarepoint Ops Llc | Sell | -89,369 | -78.2% | 24,904 | $199.48K | Q2 2026 | Aug 14, 2026 |
| State Of Wisconsin Investment Board | Sell | -57,736 | -80.6% | 13,891 | $111.27K | Q2 2026 | Aug 14, 2026 |
| Rafferty Asset Management, Llc | Sell | -54,061 | -46.0% | 63,574 | $509.23K | Q2 2026 | Aug 14, 2026 |
| Two Sigma Investments, Lp | Buy | +52,400 | — | 52,400 | $419.72K | Q2 2026 | Aug 14, 2026 |
| Sectoral Asset Management Inc | Sell | -49,250 | -62.2% | 29,900 | $239.50K | Q2 2026 | Aug 14, 2026 |
| Tudor Investment Corp Et Al | Buy | +45,895 | — | 45,895 | $367.62K | Q2 2026 | Aug 14, 2026 |
| Barclays Plc | Buy | +42,092 | +50.0% | 126,261 | $1.01M | Q2 2026 | Aug 14, 2026 |
| Invesco Ltd. | Buy | +38,891 | — | 38,891 | $311.52K | Q2 2026 | Aug 14, 2026 |
| Wells Fargo & Company/Mn | Buy | +32,610 | +107.3% | 62,995 | $504.59K | Q2 2026 | Aug 14, 2026 |
Frequently asked questions about SPRY activity
Which institutional owners are buying SPRY?
Institutional owners buying SPRY include investors who have either initiated new positions or increased their existing holdings based on recent SEC 13F filings. The activity table above highlights which funds added shares in the latest reporting periods and how their positions changed over time.
What does "buy" mean in SPRY activity?
"Buy" means an investor increased their reported position in SPRY compared to the prior reporting period. This reflects growing exposure to ARS PHARMACEUTICALS INC (SPRY) rather than necessarily a brand-new position (though new positions also appear as buys when prior quantity was zero).
Is institutional interest in SPRY increasing?
Institutional interest in SPRY can be assessed by comparing the number of tracked funds adding or increasing positions versus those trimming or exiting across the periods shown. A higher number of additions typically signals increasing participation among large filers, but it should be read alongside position sizes and the full table.
Related SPRY Institutional Insights
- SPRY Overview
- SPRY 13F Institutional Holders
- SPRY Top Institutional Shareholders
- Healthcare Sector Institutional Ownership
- Healthcare Sector Portfolio Overlap
- Institutional Portfolio Overlap & Shared Holdings
- Most Bought Healthcare Stocks By Institutional Investors
- Most Sold Healthcare Stocks By Institutional Investors
- SPRY Insider Trading & SEC Form 4 Activity
- SPRY Articles
- Top Institutional Investor Stock Rankings